Tsila Zuckerman

5.1k citations

125 papers · 2.5k indexed · 1 hit paper · h-index 24

Impact in

Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Genetics top 2%
- Mesenchymal stem cell research

Papers in

Hematology 70
- Hematopoietic Stem Cell Transplantation 39
- Acute Myeloid Leukemia Research 38
- Chronic Myeloid Leukemia Treatments 12
Genetics 25
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Chronic Lymphocytic Leukemia Research 9

Co-authors: Jacob M. Rowe Israel Henig Eli Zuckerman Reuven Or Irit Avivi Mohamad Mohty Jeff Szer Eva Wagner
Journals: Blood (36 papers)Bone Marrow Transplantation (10 papers)Current Opinion in Hematology (5 papers)Cancer (4 papers)Biology of Blood and Marrow Transplantation (4 papers)
Partner nations: Israel United States France

In The Last Decade

Tsila Zuckerman

116 papers receiving 2.5k citations

Hit Papers

align trajectories log scale

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease 2020 · 484 citations

Peers

Countries citing papers authored by Tsila Zuckerman

Since Specialization

Citations

This map shows the geographic impact of Tsila Zuckerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsila Zuckerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsila Zuckerman more than expected).

Fields of papers citing papers by Tsila Zuckerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsila Zuckerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsila Zuckerman. The network helps show where Tsila Zuckerman may publish in the future.

Co-authors

The 25 scholars most cited alongside Tsila Zuckerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tsila Zuckerman Line = papers co-authored together Tsila Zuckerman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Primary results from Equator, a Phase 3 double-blind, randomized placebo-controlled study evaluating itolizumab in combination with corticosteroids as initial treatment of acute graft-versus-host disease. Blood ·John Koreth, Maria Carmen Martinez Munoz, Jeremy Pantin, Shukaib Arslan, Jaime Sanz, Alison W. Loren, Benedetta Rambaldi, Elisa Sala, Avichai Shimoni, Tsila Zuckerman, Corey Cutler, Lisette M. Acevedo, Kham Phenis, Eugene Sun, Stephen Connelly, Joel H. Rothman	2025	0
2	CCR5 predicts neurotoxicity in CAR‐T‐cell therapy British Journal of Haematology ·Ayal Rozenberg, Shahar Shelly, Raz Winer, Riva Fineman, Steven T. Haller, Shimrit Ringelstein‐Harlev, Israel Henig, Dana Yehudai‐Ofir, Tsila Zuckerman, Tamar Tadmor, Reut Harel, Esther Ganelin‐Cohen, Ofrat Beyar‐Katz	2025	1
3	Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study Bone Marrow Transplantation ·Ilan Youngster, Adi Eshel, Mika Geva, Ivetta Danylesko, Israel Henig, Tsila Zuckerman, Shalev Fried, Ronit Yerushalmi, Noga Shem‐Tov, Joshua Fein, David Bomze, Avichai Shimoni, Omry Koren, Roni Shouval, Arnon Nagler	2024	7
4	Altered Serum Alpha1-Antitrypsin Protease Inhibition before and after Clinical Hematopoietic Stem Cell Transplantation: Association with Risk for Non-Relapse Mortality International Journal of Molecular Sciences ·Ido Brami, Tsila Zuckerman, Ron Ram, Batia Avni, Galit Peretz, Daniel Ostrovsky, Yotam Lior, Caroline Faour, Oisín F. McElvaney, Noel G. McElvaney, Eli C. Lewis	2023	1
5	Response rates of extra‐nodal diffuse large B cell lymphoma to anti‐CD19‐CAR T cells: A real word retrospective multicenter study European Journal Of Haematology ·Ofrat Beyar‐Katz, Chava Perry, Sigal Grisariu‐Greenzaid, Dana Yehudai‐Ofir, Efrat Luttwak, Batia Avni, Tsila Zuckerman, Inbal Sdayoor, Polina Stepensky, Shimrit Ringelstein‐Harlev, Yael Bar‐On, Diana Libster, Liat Sharvit, Odelia Amit, Uri Greenbaum, Ronit Gold, Yair Herishanu, Noam Benyamini, Irit Avivi, Ron Ram	2023	4
6	Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study Bone Marrow Transplantation ·Joseph P. McGuirk, Leland Metheny, Luis Piñeiro, Mark R. Litzow, Scott D. Rowley, Batia Avni, Roni Tamari, Hillard M. Lazarus, Jacob M. Rowe, Michal Sheleg, Daniel Rothenstein, Nitsan Halevy, Tsila Zuckerman	2023	2
7	Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Vaccines ·Israel Henig, Jonathan Isenberg, Dana Yehudai‐Ofir, Ronit Leiba, Shimrit Ringelstein‐Harlev, Ron Ram, Batia Avni, Odelia Amit, Sigal Grisariu, Tehila Azoulay, Ilana Slouzkey, Tsila Zuckerman	2023	3
8	A Comprehensive Toxicity and Efficacy Analysis of Different Bridging Therapies Prior to Anti CD19-CAR-T Cell Therapy in Patients with DLBCL- a National Multi-Center Cohort Study Blood ·Ron Ram, Sigal Grisariu, Liat Shargian, Dana Yehudai‐Ofir, Irit Avivi, Orit Gutfeld, Polina Stepensky, Tsila Zuckerman, Moshe Yeshurun, Odelia Amit, Batia Avni, Ronit Gurion, Yael Bar‐On, Ofrat Beyar‐Katz, Ronit Gold, Shimrit Ringelstein, Itai Levi, Tzvi Porges, Chava Perry	2021	0
9	Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission Bone Marrow Transplantation ·Jaime Sanz, Myriam Labopin, Miguel Á. Sanz, Mahmoud Aljurf, Aïda Botelho de Sousa, Charles Craddock, Tsila Zuckerman, Hélène Labussière‐Wallet, António Campos, Giovanni Grillo, Zübeyde Nur Özkurt, Jan J. Cornelissen, Péter Reményi, Massimo Martino, Rocío Parody Porras, Arnon Nagler, Norbert Claude Gorin, Mohamad Mohty, (unknown)	2020	22
10	Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performance Bone Marrow Transplantation ·Hilit Levy‐Barazany, Liat Shachnai-Pinkas, Galina Rodionov, Alex Saar, Michal Rosenzwaig, Liron Gez, Anastasia Rodin, Nitzan Marelly, Michal Abraham, Inbal Mishalian, Hila Wildbaum, Tamar Katz, Yuval Baar, Shai Yarkoni, Ronit Bakimer-Kleiner, Amnon Peled, Tsila Zuckerman, Jerry Stein	2020	2
11	Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study Blood Advances ·Moshe Yeshurun, Uri Rozovski, Oren Pasvolsky, Ofir Wolach, Ron Ram, Odelia Amit, Tsila Zuckerman, Anat Pek, Maly Rubinstein, Michal Sela-Navon, Pia Raanani, Liat Shargian	2020	6
12	Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission Bone Marrow Transplantation ·Roni Shouval, Myriam Labopin, David Bomze, Gabriela M. Baerlocher, Saveria Capria, Didier Blaise, Mathias Hänel, Édouard Forcade, Anne Huynh, Riccardo Saccardi, Giuseppe Milone, Tsila Zuckerman, Péter Reményi, Jurjen Versluis, Jordi Esteve, Norbert Claude Gorin, Mohamad Mohty, Arnon Nagler	2020	6
13	Biomarker Analysis in Patients (pts) with Steroid-Refractory Acute Graft-Vs-Host Disease (aGVHD) Treated with Ruxolitinib (RUX) or Best Available Therapy (BAT) in the Randomized, Phase 3 REACH2 Study Blood ·Gèrard Socié, Dietger Niederwieser, Nikolas von Bubnoff, Mohamad Mohty, Jeff Szer, Reuven Or, Jason Butler, Eva Wagner, Édouard Forcade, Jaime Sanz, Domenico Russo, Giovanni Grillo, Tsila Zuckerman, Sinem Civriz Bozdağ, David Ritchie, Shalini Chaturvedi, Anirudh Prahallad, Karen Sinclair, Celine Wilke, Robert Zeiser	2020	2
14	Aberrant B cells, autoimmunity and the benefit of targeting B cells in chronic graft-versus-host disease Autoimmunity Reviews ·Dana Yehudai‐Ofir, Israel Henig, Tsila Zuckerman	2020	12
15	Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantation Leukemia & lymphoma ·Ofrat Beyar‐Katz, Noa Lavi, Shimrit Ringelstein‐Harlev, Israel Henig, Dana Yehudai‐Ofir, Nuhad Haddad, Riva Fineman, Yishai Ofran, Yuval Nov, Dvora Sahar, Nivin Moustafa-Hawash, Jacob M. Rowe, Tsila Zuckerman	2019	10
16	BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study Blood Advances ·Tsila Zuckerman, Ron Ram, Luiza Akria, Maya Koren‐Michowitz, Ron Hoffman, Israel Henig, Noa Lavi, Yishai Ofran, Netanel A. Horowitz, Olga Nudelman, Sigal Tavor, Shay Yeganeh, Stela Gengrinovitch, Liat Flaishon, Shoshi Tessler, Ruth Ben Yakar, Jacob M. Rowe	2019	10
17	Abnormal morphological and functional nature of bone marrow stromal cells provides preferential support for survival of acute myeloid leukemia cells International Journal of Cancer ·Shlomit Yehudai‐Resheff, Shira Attias‐Turgeman, Rawan Sabbah, Tal Gabay, Raneem Musallam, Anna Fridman‐Dror, Tsila Zuckerman	2018	19
18	Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission American Journal of Hematology ·Xavier Poiré, Myriam Labopin, Emmanuelle Polge, Didier Blaise, Patrice Chevallier, Johan Maertens, Éric Deconinck, Édouard Forcade, Alessandro Rambaldi, Gabriela M. Baerlocher, Tsila Zuckerman, Liisa Volin, Harry C. Schouten, Norbert Ifrah, Mohamad Mohty, Jordi Esteve, Arnon Nagler	2018	13
19	Transformation of Sézary Syndrome Into CD30+ Anaplastic Large T-Cell Lymphoma After Alemtuzumab Therapy With Evidence of Clonal Unity American Journal of Dermatopathology ·Mariela J. Nevet, Tsila Zuckerman, Dvora Sahar, Richard N. Bergman	2014	4
20	Cancer-Related Sources of Stress for Children With Cancer and Their Parents Journal of Pediatric Psychology ·E. M. Rodriguez, Michael J. Dünn, Tsila Zuckerman, Kathryn Vannatta, Cynthia A. Gerhardt, Bruce E. Compas	2011	165

About Tsila Zuckerman

Tsila Zuckerman is a scholar working on Hematology, Genetics, Oncology, Immunology and Public Health, Environmental and Occupational Health, having authored 125 papers that have together received 2.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (39 papers), Acute Myeloid Leukemia Research (38 papers), Acute Lymphoblastic Leukemia research (20 papers), Chronic Myeloid Leukemia Treatments (12 papers), Neutropenia and Cancer Infections (11 papers), CAR-T cell therapy research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (9 papers). The work is most often cited by research in Hematology (945 citations), Genetics (479 citations), Molecular Medicine (168 citations), Hepatology (213 citations) and Transplantation (68 citations). Tsila Zuckerman has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Jacob M. Rowe, Israel Henig, Eli Zuckerman, Reuven Or, Irit Avivi, Mohamad Mohty, Jeff Szer, Eva Wagner, Jason Butler and Celine Wilke. Their work appears in journals such as Blood, Bone Marrow Transplantation, Current Opinion in Hematology, Cancer and Biology of Blood and Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact